Table 4.
Scheme of the central composite design: independent values, experimental values of the response variables and overall desirability (D)
Runs | Coded values | Responses | Desirability (D) |
||||
---|---|---|---|---|---|---|---|
X1 | X2 | Y1 | Y2 | Y3 | Y4 | ||
1 | −1 | 1 | 82.18 | 0.41 | 62.1 | 23.2 | 0.69 |
2 | 1 | −1 | 88.53 | 0.36 | 82.6 | 15.3 | 0.38 |
3 | 0 | 0 | 93.87 | 0.39 | 68 | 19.3 | 0.63 |
4 | 0 | −1.41 | 94.54 | 0.45 | 74 | 18.6 | 0.69 |
5 | 0 | 0 | 94.23 | 0.42 | 65.6 | 16.6 | 0.66 |
6 | −1.41 | 0 | 86.57 | 0.43 | 45.3 | 27.3 | 0.92 |
7 | 1.41 | 0 | 79.11 | 0.33 | 90.7 | 12.6 | 0.16 |
8 | −1 | −1 | 84.8 | 0.41 | 59.4 | 25.9 | 0.77 |
9 | 0 | 0 | 92.15 | 0.4 | 67.3 | 15.9 | 0.58 |
10 | 1 | 1 | 74.3 | 0.32 | 73.7 | 17.2 | 0.27 |
11 | 0 | 1.41 | 60.2 | 0.32 | 61.3 | 20.5 | 0.30 |
12 | 0 | 0 | 96.2 | 0.4 | 69.6 | 16.4 | 0.61 |
Note: Experimental batch included 4 factorial runs, 4 axial runs and 4 center points.
Abbreviations: X1, oil/mixed-surfactants ratio; X2, proportion of aqueous phase; Y1, encapsulation efficiency (%); Y2, drug loading (%); Y3, particle size (nm); Y4, zeta potential (mV).